Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DaiS who wrote (12781)	8/6/1998 5:55:00 PM
From: VLAD	Read Replies (1) \| Respond to of 23519

based on my guestimation we now have about 20k hard core MUSE patients. I believe that this number can easily triple in the next 6 months with a strong marketing team focusing on the PCP's If this happened we would see the refills eventually above the old 5,000 level but this can't happen until we see some sort of sharp increase in the number of new scripts. Time is money and Vivus is losing a lot of potential domestic income by not signing a domestic partner yesterday. What can be left to negotiate over the past month? Either the likes of J&J will buy this company otherwise how long can they quibble over unit costs? Please Mr. Wilson do something now before the short interest shaves our heads bald.